Category: Family

Supporting healthy glycemic control

Supporting healthy glycemic control

Diabetes Care. Managing your stress levels blycemic exercise or relaxation Supporting healthy glycemic control like yoga may help you regulate blood sugar levels. Here are some ideas. Behavior change techniques implemented in electronic lifestyle activity monitors: a systematic content analysis.

Supporting healthy glycemic control -

Objective: Effective diabetes self-management can prevent long-term health complications but is often complex and difficult to achieve.

Health care professionals' support for patients' autonomy autonomy support in managing their diabetes contributes to better diabetes self-care and glycemic control. Most adults with diabetes also receive self-management support from informal health supporters.

Yet, the role of autonomy support from these informal health supporters has not been explored. We examined patients' perceived autonomy support from their main health supporter family member or friend in relation to their diabetes distress, self-efficacy, self-monitoring of blood glucose SMBG , medication adherence, and hemoglobin A1c HbA1c.

Method: Three hundred twenty-six veterans with Type 2 diabetes at high risk for complications, who identified a main health supporter, were surveyed using self-report measures of social support, diabetes distress, self-efficacy, and self-care. Pölten University of Applied Sciences, the staff member will explain the trial background, protocol, different roles, importance of randomization and adherence to potential participants and will review the consent form.

Furthermore, the staff member will answer any questions arising. When the trial and its requirements are understood completely, the informed consent form will be signed by the participant. This can be done via electronic or handwritten signature.

All eligible participants must complete the consent procedure before enrolment and randomization. There are separate consent forms for general participants and for moderators.

Participants and moderators will get a financial compensation in the amount of 50 EUR and a small gift after the last measurement. Furthermore, the results of the Bioelectrical Impedance Analysis measurements BIA in the context of body weight, body height, waist circumference, and blood pressure can be discussed with a dietitian for free after each measurement.

mattermost is an instant messaging service application that is installed on the cell phone and works similar to WhatsApp, i. Unlike WhatsApp, the messenger allows to track conversations and metadata of the participants, but mattermost is hosted in an ISO-certificated data center in Vienna for the duration of the project.

Thus, it is hosted according to the European General Data Protection Regulation. The mattermost Starter Version self-managed is available for free, but the setup and secure hosting as well as the secure data extraction implementation is chargeable.

For our participants, it has the look and feel of frequently used messenger tools, e. The intervention is developed and conducted by an interdisciplinary team.

Dietitians and moderators play an active role in the operational process of the intervention. Dietitians are part of the team that develops the training curricula and is responsible for the training of the moderators and participants.

They will supervise all moderators once a month via online meetings. During these meetings, the dietitians support moderators, e. Moderators act as facilitators and coordinators but they do not give medical or disease-related advice.

In order to moderate communication and exchange in the IMS group effectively and authentically, personal and practical disease-related experiences of the moderator and the readiness to share these experiences with the group are essential.

Moderators receive 9 h of training on the content to be shared via IMS and communication strategies to facilitate group exchange, peer support and behavioral change. Participants who are randomly assigned to the intervention group will attend a 2 h technical training in connection with the first measurement.

In the course of this training, they will learn how to use the mattermost app. For the first 7 months of the intervention, an empowerment-based IMS communication strategy for diabetes self-management peer support has been developed.

Moderators are provided with a detailed handbook on web-based diabetes-related content and communication strategies to share this content with the group. The IMS strategy combines two aspects that are essential for IMS diabetes self-management peer support: 1.

a communication strategy that takes into account the special requirement of IMS communication, i. a diabetes self-management support strategy to make sure that all topics which are known to be of importance for diabetes self-management [ 49 ] are covered and shared in a way that enables and empowers participants in their disease management.

Thus, the IMS communication strategy contains, on the one hand , the IMS strategy which also involves a communication strategy that considers the special requirements of IMS and peer-communication on how to react and act in certain situations, for example, to achieve engagement.

On the other hand, it entails a didactic plan which outlines how, in what form and how frequently diabetic content shall be shared with the participants by moderators e.

This IMS strategy will be operationalized in form of the training curriculum. The moderator and the way she or he communicates with the group plays a vital role in guiding the group, setting the tone and creating an atmosphere of trust and providing support.

By introducing the moderators to certain communication strategies that are also displayed in detail in the guidebook and can be reflected upon in the monthly meeting with the dietitian, a trusting atmosphere in the IMS group should be facilitated. After the intervention, a 7 month follow-up will be conducted.

During the follow-up, the intervention group may use the IMS tool in a self-organized manner, i. Participants who are assigned to the control group will continue to receive their standard therapy but will not be assigned to a mattermost group.

The intervention will be conducted twice to increase the recruitment phase. The first intervention will start in April As soon as the first cohort enters the unaccompanied phase, a second moderated cohort will start - in both cases accompanied by an equally large control group.

With the start of the first intervention, we will have as many intervention and control teams with 14 people each as there are registrations. With the second intervention date, the remaining persons in total form further intervention and control teams. Participants can revoke their willingness to participate at any time, even without giving reasons, and withdraw from the clinical study without this causing them any disadvantages for their further medical care.

The reasons for this may be:. The communication protocols see also {12} based on activities within the IMS tool mattermost are reviewed weekly. The results of these reviews are used-in addition to the planned analysis of the KPIs-to monitor the intervention group and to intervene if necessary.

Thus, they help the study coordinator and selected study team members to stay informed and, in case of extraordinary events e. If a participant does not adhere to the communication rules netiquette previously agreed upon in each IMS group, even after several discussions, he or she will be excluded.

The intervention consists of a peer-supported IMS intervention in addition to standard therapy. Therefore, adherence of participants to the IMS intervention pertains mainly to the IMS strategy, the measurements, and the initial training sessions. The first step to improve adherence is the holistic explanation of the trial to interested participants during the initial appointment [ 50 , 51 ].

In this appointment, sufficient time is scheduled in order to enable comprehensive understanding concerning the trial among participants. at , which is provided by the Austrian Health Insurance Fund. Hence, they are already proven to be generally adherent and engaged in their disease management.

These moderators will positively influence their group members through the role model effect. A dietitian experienced in counseling will support the moderators if problems arise and they will supervise all moderators once a month via online meetings.

During the supervision, the dietitian will reflect on the past month and discuss the next steps of the IMS strategy with the moderators. If necessary, the communication expert can provide further assistance during these meetings. Furthermore, we expect an additional positive social effect: participants will identify with their mattermost group and, in the next step, with the DiabPeerS trial.

Hence, they will be interested in a successful intervention and participate actively. Also, frequent personal contact between the central study staff EH, MH, AEZ and the participants throughout the whole trial initial appointment, four measurements, supervision meetings will support adherence [ 50 ].

The IMS strategy see {11a} , the core element of this trial, aims to improve diabetes self-management. Taking into consideration that regular medical appointments and monitoring are central in diabetes self-management, we assume that this increasing competence will support adherence to intervention as well.

Additionally, clinical visits will be designed as conveniently for the participants as possible [ 50 , 51 ]. The participants will have easy access to the locations of training sessions and measurements: they can choose one out of four central locations in Lower Austria for their measurements.

These locations are well known and easily accessible: the St. Pölten University of Applied Sciences and hospitals in Wr. These locations are equally distributed over Lower Austria from a geographical point of view and can be reached comfortably by car as well as public transport. The training sessions for the participants will take place after the first measurement at the same location.

The training sessions for the moderators will be held at the St. Pölten University of Applied Sciences. Therefore, only individuals from St. Pölten or the surrounding areas are eligible to become moderators.

If a participant misses one measurement, it is possible to make a new appointment within a certain timeframe. During each measurement, participants and moderators will have the opportunity to discuss their results, such as body composition, with an experienced dietitian, which is not very common in Austria and will increase engagement [ 50 ].

Additionally, participants and moderators will receive a financial compensation of 50 EUR and a small gift after the last measurement. at [ 52 ] during the trial. This program was launched in Austria in and aims to organize long-term and high-quality care for patients with type 2 diabetes mellitus.

It is voluntary and free of charge for physicians as well as for patients. It implements evidence-based clinical guidelines and supports patient empowerment, regular medical examinations, and lifestyle advice [ 52 ].

At the end of , 14, patients with type 2 diabetes mellitus and doctors in Lower Austria - or 93, patients with type 2 diabetes mellitus and doctors at the national level - participated in this disease management program according to internal data of the Austrian Health Insurance Fund.

Trial participation entails only minimal risk compared to standard therapy alone, which will be continued after the trial.

Therefore, no special provisions for post-trial care are included. Based on this information, three levels of physical activity low, moderate, high are calculated and expressed in metabolic equivalent of task MET minutes per week.

While the first ten items are calculated to a score and four sub scores diet, exercise, blood-glucose testing, foot care , the eleventh item focuses on smoking habits.

Clinic and communication visits health professional visits in the past 6 months, hospital stays in the past 6 months. The device measures body weight with a scale, body height with ultrasound length measurement and body composition by the voltage drop of the alternating current in one step.

Waist circumference [cm] to calculate the waist-to-height ratio as measured using an ergonomic, step less, and extendible measuring tape. Additionally, demographic data and personality traits will be surveyed in the baseline assessment T0.

Demographic data include age, gender, education, living arrangement marital status , income, employment status, immigration background [ 63 ], and clinical information age at diagnosis, on insulin, other medical therapies, list of prescribed medications.

Personal traits will be assessed using the Big Five Inventory German BFI-2 [ 64 ]. As part of the data export solution of the IMS communication data, an export script is provided in which individual rooms - these correspond to the groups assigned for the experiment - are listed. Such communication protocols containing the communication data of the individual groups can be retrieved on a daily basis.

These data include, for example, the persons who have sent a post, sent texts and files, timestamps, or quotes. This information will be used to quantify the IMS communication activities.

The posts will be evaluated by content analysis to explain and interpret the results of H2 diabetes self-management behaviors, H3 quality of life of participants, and H4 medication adherence of participants. The codebook will be developed in collaboration with medical professionals for the coding of adherence and non-adherence behaviors.

The quantified data will then be made available for the in-depth analysis of questionnaire data and medical scores. According to past research [ 65 , 66 , 67 ], personality traits such as extraversion can influence our communication behavior: extraverted individuals speak more often, make more eye contact, smile, and nod more frequently than introverted persons.

H5 Therefore, we assume that extraversion will correlate positively with the number of posts as well as the number of reactions and emojis to posts from others. The flow diagram showing the participant timeline through the DiabPeerS study is presented in Fig.

The SPIRIT figure for this trial is given in Fig. The intervention group will be subdivided into seven IMS groups made up of 14 participants and one moderator each.

Therefore, nine moderators seven plus two for the compensation of possible drop-outs will be additionally recruited persons in total, participants plus nine moderators. Although the moderators will participate in the assessments, their data will not be included in the analyses. The Austrian Health Insurance Fund will perform a FoKo database Folgekosten database query based on defined inclusion and exclusion criteria to identify potential participants in Lower Austria.

The FoKo database is a social insurance data warehouse that is used by all health insurance providers in Austria. FoKo combines several IT accounting systems of Austrian health providers in one instrument and thus enables various analyses. FoKo collects data related to medical assistance, medication, and incapacity to work as well as in-patient stays or patient transport and dental treatment.

FoKo has registered approximately 1. Based on FoKo database queries of the years and , approximately potential participants will be identified.

The data of the Mother-Child-Booklet, which is part of the Austrian pregnancy and childhood examinations, allows to identify pregnant women with gestational diabetes in order to exclude them from the study [ 72 ]. The Austrian Health Insurance Fund will contact all identified patients with type 2 diabetes mellitus by personal letter while strictly considering data privacy.

Additionally, the Austrian Health Insurance Fund will inform all relevant physicians and internists in Lower Austria about the trial and ask them to inform their patients about the possibility to participate in the trial.

Eligible participants who have signed the informed consent will be randomized into the peer-supported IMS intervention group or the control group in a ratio. Random assignment will be conducted using virtual urn randomization during the initial appointment. For the allocation of the participants, a simple urn-based randomization is carried out.

For this purpose, an urn, in our case a digital card set, is filled with cards. The participants draw the cards themselves. This gives them the feeling that they have made their own decision and makes it easier for them to accept it, even if they do not end up in the desired group.

The drawing of the participants takes place during the initial appointment for the informed consent. Since the participants come continuously and from all over Lower Austria, interviews are conducted both in person and via video calls.

In order to make the ballot box drawing online and offline comparable, a computer-based drawing will take place in both cases, i. The test persons turn over one of cards and thus find out in which group they participate and, at the same time, receive their ID for the study.

The drawing takes place without putting the cards back. The maximum group size is 14 participants. When an intervention or control group is full, the recruitment of the next group will be started. The ID numbers are therefore not consecutive within the groups, but random.

There is no upper limit regarding the number of participants for the first recruitment date. Blinding of trial participants will not be possible because of the obvious differences between the intervention group and the control group. Blinding will be implemented for the medical staff and the outcome assessors of the measurements and the following analyses see {19}.

During the online registration, contact data of all interested individuals will be collected. The data will be deleted if the person disagrees to participate in the trial.

Pölten University of Applied Sciences either at the university itself or at the Landesklinikum Wr. The measurements will take place in the morning in a fasting state and with anthropometric measurements with light clothing.

Anthropometric measurements will be conducted by dietitians. Blood pressure and blood samples will be taken by nurses.

Fresh blood samples will be taken by the staff of the St. Pölten University of Applied Sciences, centrifuged within a timeframe of twenty minutes, and analyzed within a timeframe of 3 h maximum after the centrifugation by the University Hospital St. The laboratory of the University Hospital St.

Pölten is ISO certified and will handle all samples according to its quality management. During the follow-up, participants of the intervention group can use the instant messaging service and continue their communication with the group members and the moderator, hence, without support of the study team.

The moderator will be instructed to motivate the group members to participate in the follow-up measurement. The relationship of trust and social support in the groups as well as with the study staff will support a higher degree of complete follow-up.

The participants agree that for the purpose and in the course of this study, the St. Pölten University of Applied Sciences will collect and process the following personal data: name, age, gender, education, income, occupational situation, housing situation, migration background, personality characteristics, clinical information such as age at diabetes diagnosis, social support, self-efficacy, depression, quality of life, diabetes knowledge, treatment adherence, diet and exercise behavior, nicotine and alcohol consumption, diabetes self-management, medical consultations during the last 6 months, HbA 1c , fasting glucose, total cholesterol, HDL, LDL, triglycerides, blood pressure, body weight and height, waist circumference, and body composition.

Furthermore, the participants agree that the University Hospital St. Pölten may transmit the following data in indirectly personalized pseudonymized or encrypted form to the St.

Pölten University of Applied Sciences for the purpose of analyzing whether the intervention is effective with regard to the defined parameters compared to conventional therapy: HbA 1c , fasting glucose, total cholesterol, HDL, LDL, triglycerides. This code will be stored safely in a password-protected file, accessible only by the study coordinator EH and central staff members UH, AEZ.

The key for the coding is kept separately and inaccessibly by the study coordinator. Thus, it is only possible for persons who are entrusted with the evaluation of the data to infer the identity of the participants.

Data acquisition and data processing are performed using commercial software. All data obtained are stored in computer files in encrypted form.

The coding is done by means of consecutive numbering, from which only the allocation to the corresponding group, but in no case a conclusion as to the identity of the participant is possible.

Data will be stored and analyzed via the statistical software package SPSS at servers of the St. Pölten University of Applied Sciences, only used for this special study and not be passed on to third parties.

The handling of the data complies with the European General Data Protection Regulation, the Austrian Data Protection Act, and the recommendations of the Ethics Committee of Lower Austria. To be able to merge the data from the paper-and-pencil questionnaires, anthropometric measurements, and blood pressure data, a defined coding system will be used.

Therefore, the study coordinator will take part in every measurement and organize the participants and coding system. Hence, every participant will get his or her identification code and the questionnaires will be marked with this code at the beginning of each measurement.

The identification code ensures that the study staff do not know to which group each participant belongs. Paper-and-pencil questionnaires will be checked by the study staff in terms of completeness and correctness related to the specifications of the questionnaires.

These data will be transferred into SPSS manually and controlled by another member of the study team. Results of the biochemical analysis will be mailed via encrypted Excel files from the University Hospital St. Pölten to the St. Pölten University of Applied Sciences and imported into SPSS by the study coordinator.

Blood samples will be disposed of and Excel files will be deleted after integration into SPSS. Furthermore, the St. Pölten University of Applied Sciences performs data back-ups on a daily basis.

All signed informed consent forms as well as all collected paper-and-pencil sheets will be stored in a locked place, accessible only to the study coordinator and a central staff member UH.

All data will be stored at the St. After that, all data will be destroyed. To ensure data quality, the study coordinator will control the data regularly including checking the range of values or double data entry. mattermost has been chosen for its clear terms and conditions and data handling strategy.

The open-source software mattermost was chosen because it can be operated securely and privately, as we will run it on-premise and not as a cloud solution. mattermost will be hosted as a software solution in an ISO certified data center in Vienna for the duration of the project.

The data export based on Docker is conducted in the Viennese data center and made available only to selected members of the study team EH, AEZ, JG.

The data are cleaned, and unstructured communication data will be structured using content analysis and MAXQDA see {12}. Subsequently, these data will be pseudonymized and transferred into SPSS for further analysis. Only the study coordinator and central staff members UH, AEZ can open the password-protected file to link personal information and code.

The final pseudonymized dataset in SPSS will be used by the study staff for analyses, publications, and reports only for this study. Data will be analyzed using IBM SPSS Statistics 26 or greater IMB Corporation, Armonk, NY, USA.

Generally, metric data will be checked for normal distribution using a histogram of each variable, as well as for skewness and kurtosis. Interval variables or nominal scaled variables will be shown as frequencies. Repeated measures ANCOVA will be used to compare the control and intervention groups concerning primary and secondary outcome parameters.

Non-normal metric data will be analyzed using the Mann-Whitney U test, the Kruskal-Wallis signed rank test, or the Friedman-Test [ 73 ]. There will be no planned interim analysis or stopping guidelines for medical reasons besides the exclusion criteria see {10} because no potentially harmful outcomes are expected based on the peer-supported IMS intervention.

Nevertheless, participants can be excluded from the intervention group if they do not follow the rules of interaction set and agreed upon in the IMS group see {11b}. As we want to assess the association between specific personality traits and the benefits of peer-supported IMS, we use validated and published questionnaires, which we repeatedly distribute to all experimental and control groups at different times of the study.

In addition to the observed communication behavior, we use the information from the questionnaires see {12} to test the hypotheses and in particular related to H2 diabetes self-management behaviors, H3 quality of life of participants, and H4 medication adherence as well as H5 the level of extraversion.

For these cases, the nearest neighbor method will be used to replace missing data points. Furthermore, we will check the randomness of missing data by calculating the MCAR missing completely at random classification.

It is not planned to give third parties access, neither to the full protocol, nor the participant data, nor the statistical code.

The complexity of diabetes therapy demands interdisciplinary teams and innovative treatment approaches. This consortium meets these requirements and combines life sciences, nutritional sciences and dietetics, human medicine, psychology, and with media economics, communications, and sociology in a unique constellation.

Responsibilities are assigned on the basis of the expertise of the respective study team members. Responsible persons for the following areas are defined as relevant to the study: Instant Messaging Service Interventions, Dietetics, Medical Measurements, Recruitment, and Biochemical Analyses and Statistics.

In addition, two persons are available as supervisors for the areas of Nutrition and Communication, respectively, and a medical doctor is also part of the study team. Meetings of the entire study team are held every 2 months or more frequently when meetings are needed or in subgroups.

In addition, experts are available on request. Decisions are made democratically. The study coordinator has the final responsibility. Ethics approval has been obtained from the local Ethics Committee prior to the start of the study see {24}.

Technical know-how is mainly outsourced to the service units of the instant messaging service mattermost. On the one hand, the role of the committee members AEZ, JG is to conduct weekly checks of the communication protocols and to identify potential errors in measurement or possible anomalies in the behaviors of participants and moderators.

In addition, members of the DMC EH, UH routinely check that adequate procedures are in place to ensure that the data remain confidential and that there are no data breaches. If security problems are identified, the Data Monitoring Committee informs the other study members or, depending on the severity of the problem, also the funding agency, and takes action to fix the problem.

Although we consider specific risks for participation very low, a system for collecting, assessing, reporting, and managing adverse events will be implemented. Every potential adverse event will be documented in detail.

Furthermore, the study team will control the communication data for problematic situations at regular intervals. The dietitians will address this topic during the monthly meetings with the moderators as part of the process evaluation.

The meetings will be conducted at least twice a year and a maximum of every 2 months. The study coordinator EH and central staff members UH, AEZ meet twice a month to review the trial conduct. The study coordinator reports to the Ethics Committee as well as to the funding organization at least once a year.

If adoptions of the study protocol will become essential, further notifications will be made to these organizations by the study coordinator.

Approval for protocol modification will be sought for from the Ethics Committee of Lower Austria as well as the funding organization Gesellschaft für Forschungsförderung Niederösterreich m. H, Austria using the report form of the Ethics Committee and the funding organization.

Upon approval of all changes, we will update the clinical trial registry. If protocol modifications differ from what was explained to participants when signing the informed consent, the participants will be informed immediately about all changes and re-consent will be sought by a study staff member dietitian or nutritionist.

The consortium has developed a dissemination plan which defines all relevant stakeholders and appropriate dissemination strategies as well as authorship guidelines [ 74 ] visualized in a GANTT chart including when to conduct which dissemination activity, and another tool for the documentation of all activities.

The dissemination plan includes scientific as well as general dissemination activities. All dissemination activities will be documented and reported by the responsible consortium member.

When it comes to scientific dissemination, the study protocol and the study results will be published in peer-reviewed open access journals. The study and its results will be presented at scientific conferences. Various activities are planned to disseminate generally, e. Type 2 diabetes mellitus is one of the major global causes of disability and mortality.

During the past few decades, the prevalence of diabetes increased dramatically all over the world and rising numbers are expected for the next decades [ 1 , 2 ]. Additionally, data indicate that the COVID pandemic will worsen the global diabetes burden because of the bi-directional relationship between these two diseases: on the one hand, diabetes is associated with a poor prognosis of COVID, and COVID patients with diabetes are more likely to face uncontrolled hyperglycemia or acute hyperglycemic crisis.

On the other hand, a recent meta-analysis with approximately participants shows a pooled proportion of Furthermore, the COVID pandemic is suspected to have long-term effects on the prevalence of type 2 diabetes mellitus because of the lockdowns in almost every country.

This unique situation has led to harmful effects such as increased calorie intake, reduced physical activity, increased screen time, weight gain, depression, boredom, disrupted sleep pattern, anxiety, and stress [ 76 , 77 ]. The majority of these effects are well-known risk factors for the development of type 2 diabetes mellitus [ 10 ].

This situation highlights the importance of appropriate diabetes management. DSMES is a key component of successful diabetes management and it is highly relevant to maintain the positive results in the long run. Therefore, DiabPeerS aims to improve diabetes self-management leading to better glycemic control by implementing a peer-supported IMS intervention in addition to standard care.

IMS provides several benefits:. IMS can be used time- and location-independently, which leads to higher participation rates of people with type 2 diabetes mellitus in diabetes self-management support offers.

the majority of patients with diabetes already use IMS, which means that no technology barrier is perceived. IMS groups can be supervised by different health professionals at the same time or used to share workload or offer additional support.

The additional support is an option of information verification, which increases the quality of the peer support.

To ensure positive effects of peer-supported IMS interventions, participants, moderators, and health professionals should undergo adequate training because IMS demands very specific communication, e.

Therefore, the DiabPeerS study has developed specific trainings for participants, moderators, and dietitians. Information concerning these trainings will be published after the end of the study. Based on the multifactorial origin of type 2 diabetes mellitus and the need for holistic therapeutic approaches, the DiabPeerS study consists of an interdisciplinary team and looks at the disease requirements as well as the peer-supported IMS intervention from different scientific angles by adopting a mixed-methods approach.

On the one hand, the study team will gain new insights concerning effective strategies to support diabetes disease management and improve disease-related outcomes. On the other hand, the IMS strategy and the trial outcomes can be analyzed in detail, e.

Besides the undoubted negative consequences of the COVID pandemic, people all over the world are now used to communicating online, which has led to a digital boost in the healthcare sector. DiabPeerS is intended to make a relevant contribution to future high-quality online services for patients.

This is the protocol version 6 from Recruitment has started in August and will end in September Improving glycemic control in patients with type 2 diabetes mellitus through a peer support instant messaging service intervention.

World Health Organization: Global report on diabetes. Geneva: WHO; Accessed 4 Jan International Diabetes Federation: IDF Diabetes Atlas. Ninth edition Brussels: IDF; Accessed 20 Nov Schmutterer I, Delcour J, Griebler R. Österreichischer Diabetesbericht Vienna: Bundesministerium für Gesundheit und Frauen; Österreichische Diabetes Gesellschaft.

Diabetes mellitus - Anleitungen für die Praxis. Wien Klin Wochenschr. Google Scholar. Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Bärnighausen T, et al.

Lancet Diabetes Endocrinol. Article PubMed Google Scholar. American Diabetes Association. Economic Costs of Diabetes in the U. in Diabetes Care. Article PubMed Central Google Scholar. Funnell MM, Anderson RM. The Problem With Compliance in Diabetes.

Article CAS PubMed Google Scholar. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes - International Diabetes Federation: Global Guideline for Type 2 Diabetes. Paulweber B, Valensi P, Lindström J, Lalic NM, Greaves CJ, McKee M, et al.

A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes. Horm Metab Res. Article CAS Google Scholar. Powers MA, Bardsley JK, Cypress M, Funnell MM, Harms D, Hess-Fischl A, et al.

Mulcahy K, Maryniuk M, Peeples M, Peyrot M, Tomky D, Weaver T, et al. Diabetes self-management education core outcomes measures. Diabetes Educ. Bekele BB, Negash S, Bogale B, Tesfaye M, Getachew D, Weldekidan F, et al.

Effect of diabetes self-management education DSME on glycated hemoglobin HbA1c level among patients with T2DM: Systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr. Odgers-Jewell K, Ball LE, Kelly JT, Isenring EA, Reidlinger DP, Thomas R.

Effectiveness of group-based self-management education for individuals with Type 2 diabetes: a systematic review with meta-analyses and meta-regression. Diabet Med J Br Diabet Assoc. Tanaka R, Shibayama T, Sugimoto K, Hidaka K.

Diabetes self-management education and support for adults with newly diagnosed type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract.

World Health Organization. Use of glycated haemoglobin HbA1c in the diagnosis of diabetes mellitus. He X, Li J, Wang B, Yao Q, Li L, Song R, et al. Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis.

Minet L, Møller S, Vach W, Wagner L, Henriksen JE. Mediating the effect of self-care management intervention in type 2 diabetes: a meta-analysis of 47 randomised controlled trials.

Patient Educ Couns. Steinsbekk A, Rygg LØ, Lisulo M, Rise MB, Fretheim A. Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus.

A systematic review with meta-analysis. BMC Health Serv Res. Article PubMed PubMed Central Google Scholar. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM.

Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Shumaker SA, Brownell A.

Toward a Theory of Social Support: Closing Conceptual Gaps. J Soc Issues. Article Google Scholar. Song Y, Nam S, Park S, Shin I-S, Ku BJ. The Impact of Social Support on Self-care of Patients With Diabetes: What Is the Effect of Diabetes Type?

Systematic Review and Meta-analysis. Wang X, He L, Zhu K, Zhang S, Xin L, Xu W, et al. An integrated model to evaluate the impact of social support on improving self-management of type 2 diabetes mellitus.

BMC Med Inform Decis Mak. Powers MA, Bardsley J, Cypress M, Duker P, Funnell MM, Fischl AH, et al. Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics.

Clin Diabetes Publ Am Diabetes Assoc. Dennis C-L. Peer support within a health care context: a concept analysis. Int J Nurs Stud. Gatlin TK, Serafica R, Johnson M. Systematic review of peer education intervention programmes among individuals with type 2 diabetes.

J Clin Nurs. Patil SJ, Ruppar T, Koopman RJ, Lindbloom EJ, Elliott SG, Mehr DR, et al. Peer Support Interventions for Adults With Diabetes: A Meta-Analysis of Hemoglobin A1c Outcomes. Ann Fam Med. Effect of peer support interventions on cardiovascular disease risk factors in adults with diabetes: a systematic review and meta-analysis.

BMC Public Health. Dale JR, Williams SM, Bowyer V. What is the effect of peer support on diabetes outcomes in adults? A systematic review. Johansson T, Keller S, Winkler H, Ostermann T, Weitgasser R, Sönnichsen AC.

Effectiveness of a Peer Support Programme versus Usual Care in Disease Management of Diabetes Mellitus Type 2 regarding Improvement of Metabolic Control: A Cluster-Randomised Controlled Trial. J Diabetes Res. mHealth: new horizons for health through mobile technologies: second global survey on eHealth.

Accessed 19 Mar Eberle C, Stichling S, Löhnert M. Diabetology 4. J Med Internet Res. Morris C, Scott RE, Mars M. Security and Other Ethical Concerns of Instant Messaging in Healthcare.

Stud Health Technol Inform. Kitsiou S, Paré G, Jaana M, Gerber B. Effectiveness of mHealth interventions for patients with diabetes: An overview of systematic reviews.

PloS One. Article CAS PubMed PubMed Central Google Scholar. Wang Y, Min J, Khuri J, Xue H, Xie B, Kaminsky L, et al. Effectiveness of Mobile Health Interventions on Diabetes and Obesity Treatment and Management: Systematic Review of Systematic Reviews.

JMIR MHealth UHealth. Gabarron E, Årsand E, Wynn R. Social Media Use in Interventions for Diabetes: Rapid Evidence-Based Review. Vorderstrasse A, Lewinski A, Melkus GD, Johnson C. Social Support for Diabetes Self-Management via eHealth Interventions.

Curr Diab Rep. Statistik Austria: Erhebung über den IKT-Einsatz in Haushalten Vienna: Statistik Austria; Tang TS, Funnell M, Sinco B, Piatt G, Palmisano G, Spencer MS, et al.

Comparative effectiveness of peer leaders and community health workers in diabetes self-management support: results of a randomized controlled trial. Giordano V, Koch H, Godoy-Santos A, Dias Belangero W, Esteves Santos Pires R, Labronici P. WhatsApp Messenger as an Adjunctive Tool for Telemedicine: An Overview.

Interact J Med Res. Kleinberger JW, Pollin TI. Personalized medicine in diabetes mellitus: current opportunities and future prospects. Ann N Y Acad Sci. Scheen AJ. Precision medicine: The future in diabetes care?

Dugas M, Crowley K, Gao GG, Xu T, Agarwal R, Kruglanski AW, et al. Individual differences in regulatory mode moderate the effectiveness of a pilot mHealth trial for diabetes management among older veterans.

PLOS ONE. Klein WMP, Rothman AJ, Cameron LD. Theoretical innovations in social and personality psychology and implications for health: introduction to special issue. Health Psychol Off J Div Health Psychol Am Psychol Assoc.

Montag C, Błaszkiewicz K, Sariyska R, Lachmann B, Andone I, Trendafilov B, et al. Smartphone usage in the 21st century: who is active on WhatsApp? BMC Res Notes. Amt der NÖ Landesregierung: Bevölkerungsstruktur Zahlen Fakten, St. Accessed 28 May Statistik Austria: Bevölkerung. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R.

A Single-Question Screening Test for Drug Use in Primary Care. Arch Intern Med.

Physical Supporting healthy glycemic control is glycejic important Suppirting people Supporting healthy glycemic control diabetes! If you have diabetesbeing glycenic makes Kiwi fruit retail opportunities body more gglycemic to insulin the hormone uealthy allows cells in your body to use blood sugar for energy hea,thy, which helps manage your Dairy-free options. Physical activity also helps control blood sugar levels and lowers your risk of heart disease and nerve damage. Being physically active can be fun. The goal is to get at least minutes per week of moderate-intensity physical activity. One way to do this is to try to fit in at least 20 to 25 minutes of activity every day. Also, on 2 or more days a week, include activities that work all major muscle groups legs, hips, back, abdomen, chest, shoulders, and arms. Supportint volume 23Article number: Cite this Recovery Meal Ideas. Metrics details. Diabetes Supporting healthy glycemic control is glyecmic of the four priority Supporting healthy glycemic control diseases worldwide. It can lead to serious long-term complications and produces significant costs. Due to the chronicle character of the disease, it requires continuous medical treatment and good therapy adherence of those suffering. Research indicates that these outcomes might be difficult to maintain.

Video

Using Exercise to Improve Glycemic Control and Time in Range

Author: Voodoojin

2 thoughts on “Supporting healthy glycemic control

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com